OXYCODONE ARROW 20 mg, gélule — plaquette(s) PVC PVDC aluminium de 14 gélule(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930068649 -
CIP7
3006864 -
CIS
68397042
What the source publishes
- Holder
- ARROW GENERIQUES
- Active ingredients
- CHLORHYDRATE D'OXYCODONE, OXYCODONE
- Form
- gélule
- Package
- plaquette(s) PVC PVDC aluminium de 14 gélule(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription limitée à 4 semaines ; prescription en toutes lettres sur ordonnance sécurisée ; stupéfiants
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2016-11-03
- Prescription
- Prescription or restricted
Names this record is found by
- OXYCODONE ARROW 20 mg, gélule — plaquette(s) PVC PVDC aluminium de 14 gélule(s)
- OXYCODONE ARROW 20 mg, gélule
- CHLORHYDRATE D'OXYCODONE
- OXYCODONE
Complete source data
{
"cis": "68397042",
"cip7": "3006864",
"form": "gélule",
"name": "OXYCODONE ARROW 20 mg, gélule — plaquette(s) PVC PVDC aluminium de 14 gélule(s)",
"cip13": "3400930068649",
"holder": "ARROW GENERIQUES",
"routes": [
"orale"
],
"holders": [
"ARROW GENERIQUES"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "4.66",
"authorisedOn": "2016-11-03",
"compositions": [
{
"name": "CHLORHYDRATE D'OXYCODONE",
"nature": "SA",
"strength": "20 mg",
"linkageNumber": "1",
"substanceCode": "05087",
"dosageReference": "une gélule",
"pharmaceuticalElement": "gélule"
},
{
"name": "OXYCODONE",
"nature": "FT",
"strength": "17,93 mg",
"linkageNumber": "1",
"substanceCode": "46704",
"dosageReference": "une gélule",
"pharmaceuticalElement": "gélule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription limitée à 4 semaines ; prescription en toutes lettres sur ordonnance sécurisée ; stupéfiants",
"dispensingFee": "1.02",
"medicinePrice": "3.64",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "OXYCODONE ARROW 20 mg, gélule",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) PVC PVDC aluminium de 14 gélule(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2017-05-03",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE D'OXYCODONE",
"OXYCODONE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"prescription limitée à 4 semaines",
"prescription en toutes lettres sur ordonnance sécurisée",
"stupéfiants"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- douleurs cancéreuses sévères<br>- douleurs sévères neuropathiques<br>- traitement des fortes douleurs de l'arthrose du genou ou de la hanche et de la lombalgie chronique, en dernier recours, lorsque les solutions chirurgicales sont envisagées ou que la pose de prothèses orthopédiques est contre-indiquée ou refusée par le malade ; JOURNAL OFFICIEL ; 13/04/16",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930068649"